Text Size

Project TEAM: Teaching HIV Prevention in the HIV Clinic

This study has been completed.
Sponsor:
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00164320
First received: September 9, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The purpose of this study is to determine if the TEAM prevention intervention delivered by a physician and an HIV-positive counselor is effective. It is hypothesized that those who receive the intervention will report a higher reduction in risky sex than those who were in the standard-care condition.


Condition Intervention Phase
HIV
 Behavioral: TEAM
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Project TEAM: Teaching HIV Prevention in the HIV Clinic

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Self-reported unprotected (without condoms)anal or vaginal sex with HIV-negative or unknown-status persons.

Estimated Enrollment: 600
Study Start Date: May 2004
Estimated Study Completion Date: May 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • 1) 18 years or older, 2) HIV-infected, 3) Sexually active, 3)Receiving HIV primary care at participating clinic, 4) Can communicate in English or Spanish, 5) No previous enrollment in the TEAM study or intervention.

Exclusion Criteria:

  • 1) Participation in a similar study run by the TEAM PI.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00164320

Locations
United States, Florida
University of Miami School of Medicine
Miami, Florida, United States, 33136
Sponsors and Collaborators
Centers for Disease Control and Prevention
Investigators
Study Director: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
Principal Investigator: Lisa Metsch, PhD. University of Miami
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00164320     History of Changes
Other Study ID Numbers: CDC-NCHSTP-3699, R18/CCR420971-01
Study First Received: September 9, 2005
Last Updated: September 9, 2005
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on October 16, 2012